Atul Laddu

1.3k total citations
75 papers, 945 citations indexed

About

Atul Laddu is a scholar working on Cardiology and Cardiovascular Medicine, Anesthesiology and Pain Medicine and Surgery. According to data from OpenAlex, Atul Laddu has authored 75 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 16 papers in Anesthesiology and Pain Medicine and 12 papers in Surgery. Recurrent topics in Atul Laddu's work include Cardiac electrophysiology and arrhythmias (22 papers), Anesthesia and Sedative Agents (14 papers) and Cardiac pacing and defibrillation studies (13 papers). Atul Laddu is often cited by papers focused on Cardiac electrophysiology and arrhythmias (22 papers), Anesthesia and Sedative Agents (14 papers) and Cardiac pacing and defibrillation studies (13 papers). Atul Laddu collaborates with scholars based in United States, India and United Kingdom. Atul Laddu's co-authors include Prasad Turlapaty, Pitambar Somani, Herbert Lepor, Vishnu Murthy, Harold F. Hardman, David Henry, Randolph C. Byrd, Ramanuj Achari, John C. Somberg and Ruey J. Sung and has published in prestigious journals such as Circulation, The FASEB Journal and The American Journal of Medicine.

In The Last Decade

Atul Laddu

73 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atul Laddu United States 19 570 192 144 87 80 75 945
D. J. Sumner United Kingdom 19 265 0.5× 137 0.7× 27 0.2× 163 1.9× 112 1.4× 53 1.1k
J. Tuckman United States 14 281 0.5× 179 0.9× 36 0.3× 31 0.4× 75 0.9× 38 646
Louis Wj Australia 14 150 0.3× 103 0.5× 30 0.2× 133 1.5× 57 0.7× 29 547
Michael Davidov United States 19 505 0.9× 174 0.9× 40 0.3× 77 0.9× 113 1.4× 44 872
Albert N. Brest United States 20 723 1.3× 326 1.7× 55 0.4× 118 1.4× 401 5.0× 114 1.6k
Charles Swartz United States 25 599 1.1× 327 1.7× 45 0.3× 229 2.6× 422 5.3× 73 1.8k
Dierk Werner Germany 18 525 0.9× 188 1.0× 180 1.3× 66 0.8× 119 1.5× 43 1.2k
Chris Garratt United Kingdom 23 1.3k 2.3× 194 1.0× 138 1.0× 286 3.3× 152 1.9× 88 1.9k
Stanley H. Taylor United Kingdom 19 686 1.2× 166 0.9× 23 0.2× 53 0.6× 87 1.1× 61 902
A Polese Italy 23 1.5k 2.6× 486 2.5× 59 0.4× 199 2.3× 200 2.5× 47 2.1k

Countries citing papers authored by Atul Laddu

Since Specialization
Citations

This map shows the geographic impact of Atul Laddu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul Laddu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul Laddu more than expected).

Fields of papers citing papers by Atul Laddu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atul Laddu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul Laddu. The network helps show where Atul Laddu may publish in the future.

Co-authorship network of co-authors of Atul Laddu

This figure shows the co-authorship network connecting the top 25 collaborators of Atul Laddu. A scholar is included among the top collaborators of Atul Laddu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atul Laddu. Atul Laddu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laddu, Atul, et al.. (2025). 181 History of the Introduction of Direct Oral Anticoagulants and Their Mechanism of Action. Research and Practice in Thrombosis and Haemostasis. 9. 102831–102831.
2.
Iqbal, Omer, Fakiha Siddiqui, Nusrat Jabeen, et al.. (2021). Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey. Clinical and Applied Thrombosis/Hemostasis. 27. 2975248446–2975248446. 3 indexed citations
3.
Lenz, Martin, James L. Pool, Atul Laddu, et al.. (1995). Combined terazosin and verapamil therapy in essential hypertensionHemodynamic and pharmacokinetic interactions. American Journal of Hypertension. 8(2). 133–145. 8 indexed citations
4.
Hsu, Ping‐Hwa & Atul Laddu. (1994). Analysis of Adverse Events in a Dose Titration Study. The Journal of Clinical Pharmacology. 34(2). 136–141. 1 indexed citations
5.
Soloway, Mark S., et al.. (1992). Efficacy of Terazosin in Patients withBenign Prostatic Hyperplasia. European Urology. 21(2). 126–130. 8 indexed citations
6.
Achari, Ramanuj & Atul Laddu. (1992). Terazosin: A New Alpha Adrenoceptor Blocking Drug. The Journal of Clinical Pharmacology. 32(6). 520–523. 13 indexed citations
7.
Lepor, Herbert & Atul Laddu. (1992). Terazosin in the Treatment of Benign Prostatic Hyperplasia: The United States Experience. British Journal of Urology. 70(s1). 2–9. 22 indexed citations
8.
Somberg, John C., Ramanuj Achari, & Atul Laddu. (1991). Terazosin: Pharmacokinetics and the effect of age and dose on the incidence of adverse events. American Heart Journal. 122(3). 901–905. 9 indexed citations
9.
Cheung, Deanna G., et al.. (1991). Antihypertensive dose-response relationships: Studies with the selective α1-blocking agent terazosin. American Heart Journal. 122(3). 905–910. 7 indexed citations
10.
Strom, Joel A., Benjamin Zola, William H. Frishman, et al.. (1991). Acute hemodynamic effects of terazosin in hypertensive and normotensive patients. American Heart Journal. 122(3). 892–900. 2 indexed citations
11.
Das, Gopal D., Richard Gray, Raja W. Dhurandhar, et al.. (1988). Efficacy of Esmolol in the Treatment and Transfer of Patients with Supraventricular Tachyarrhythmias to Alternate Oral Antiarrhythmic Agents. The Journal of Clinical Pharmacology. 28(8). 746–750. 19 indexed citations
12.
Strom, Joel A., M E Josephson, William H. Frishman, et al.. (1988). Hemodynamic Effects of Flestolol, a Titratable Short‐Acting Intravenous Beta‐Adrenergic Receptor Blocker. The Journal of Clinical Pharmacology. 28(3). 276–282. 4 indexed citations
13.
Wallin, John D., et al.. (1988). Intravenous nicardipine for the treatment of severe hypertension. The American Journal of Medicine. 85(3). 331–338. 55 indexed citations
14.
Gerber, Nicolas U., D C Mays, Atul Laddu, et al.. (1988). Safety, Tolerance and Pharmacokinetics of Intravenous Doses of the Phosphate Ester of 3‐Hydroxymethyl‐5,5‐Diphenylhydantoin: A New Prodrug of Phenytoin. The Journal of Clinical Pharmacology. 28(11). 1023–1032. 50 indexed citations
15.
Achari, Ramanuj, et al.. (1987). Pharmacokinetics and Pharmacodynamics of Flestolol, a New Short‐Acting, Beta‐Adrenergic Receptor Antagonist. The Journal of Clinical Pharmacology. 27(1). 60–64. 4 indexed citations
16.
Löwenthal, David, R. Stephen Porter, Ramanuj Achari, et al.. (1987). Esmolol‐Digoxin Drug Interaction. The Journal of Clinical Pharmacology. 27(8). 561–566. 6 indexed citations
17.
Turlapaty, Prasad, Atul Laddu, Vishnu Murthy, Bramah N. Singh, & Robert J. Lee. (1987). Esmolol: A titratable short-acting intravenous beta blocker for acute critical care settings. American Heart Journal. 114(4). 866–885. 44 indexed citations
18.
Swerdlow, Charles D., et al.. (1987). Electropharmacology of flestolol for supraventricular tachycardia without associated structural heart disease. The American Journal of Cardiology. 60(13). 1055–1060. 2 indexed citations
19.
Byrd, Randolph C., Gopal D. Das, Robert L. Engler, et al.. (1986). Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. American Heart Journal. 111(1). 42–48. 66 indexed citations
20.
Shapiro, William, Garrett Lee, Anthony N. DeMaria, et al.. (1982). Comparison of two methods of analyzing frequency of ventricular arrhythmias. American Heart Journal. 104(4). 874–875. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. J. Sumner Breakdown of academic impact, for papers by J. Tuckman Breakdown of academic impact, for papers by Louis Wj Breakdown of academic impact, for papers by Michael Davidov Breakdown of academic impact, for papers by Albert N. Brest Breakdown of academic impact, for papers by Charles Swartz Breakdown of academic impact, for papers by Dierk Werner Breakdown of academic impact, for papers by Chris Garratt Breakdown of academic impact, for papers by Stanley H. Taylor Breakdown of academic impact, for papers by A Polese
Rankless by CCL
2026